
| |
Yale University
School of Medicine
Department of Neurology
P.O. Box 208018
New Haven, CT
06520-8018
|
|
 |

Faculty Research Interests
| Black,
Joel A., Ph.D. |
Membrane
structure in normal and pathological neurons and glia. Ion channel
expression in normal and injured neurons. Neuro-glial interactions.
Cell biology of neurological disease. |
| Blumenfeld,
Hal, M.D., Ph.D. |
Combined
electrophysiology and neuroimaging. Human functional neuroanatomy.
Epilepsy, human studies and animal models, Cortical-subcortical mechanisms
of consciousness
|
| Booss,
John, M.D. |
HIV
neurology, HIV long term care, and multiple sclerosis. |
| Bracken,
Michael, M.D. |
Epidemiology
of diseases of pregnancy and newborns with an emphasis on environmental
and genetic risk factors for causation and iatrogenic factors in patient
care. |
 |
| Carrithers,
Michael, M.D., Ph.D. |
Neuroimmunology,
with a focus on mechanisms of inflammation in the CNS and how the
response of the CNS microenvironment dictates specific disease phenotypes.
A working hypothesis is that aberrant homing of immune cells to the
brain can result in autoimmune disease such as multiple sclerosis.
|
| Dib-Hajj,
Sulayman, Ph.D. |
Molecular
biology of voltage-gated sodium channels, quantitative analysis of
gene expression in normal and injured neurons, structure-function
relationship of sodium channel alpha subunits, identification of proteins
that modulate channel properties. Molecular pathophysiology of spinal
cord dysfunction and multiple sclerosis. |
|
Duckrow, Robert, M.D.
|
|
| Eisa,
Mahmood, M.D. |
Development
and implementation of a model of care for Parkinson's disease patients
using performance measures/quality indicators. Currently developing
quality indicators for Parkinson's disease management. Also interested
in the development of current drug guidelines for use with Parkinson's
disease drugs such as Ropinirole, Entacapone, Provigil and Rivastigmine. |
| Hisama,
Fuki M., M.D. |
Molecular
genetic aspects of neurologic diseases. Function of the gene for Werner's
syndrome (adult-onset progeria). |
| Kocsis,
Jeffrey D., Ph.D. |
Pathophysiology
of axonal regeneration and demyelination and cellular transplantation.
Intracellular Ca2+ signaling mechanisms, ion channel and receptor
plasticity in response to injury. Studies on cellular mechanisms of
anticonvulsants such as gabapantin and vigabatrin, GABA metabolic
modulations. |
 |
|
Lo, Albert., M.D., Ph.D.
|
Pathobiology
of demyelinating disease, neuronal injury and repair, neuroprotection,
MS epidemiology, robotic neurorehabilitation, clinical trial design
and methodology |
|
Mattson, Richard H., M.D.
|
Epilepsy,
antiepileptic drug pharmacology. Intensive EEG monitoring, epilepsy
surgery, new antiepileptic drugs. Women and epilepsy. |
Ment,
Laura R., M.D.
|
Neonatal
intraventricular hemorrhage: prevention and sequelae. Cellular and
molecular studies of germinal matric microvascular maturation and
the effect of chronic sublethal hypoxia on the developing brain. |
Navaratnam,
Kumar, M.D., Ph.D.
|
|
| Novella,
Steven, M.D. |
Peripheral
neuropathy and clinical neurophysiology. Clinical management of motor
neuron disease. |
|
Novotny,
Edward J.,Jr., M.D. |
Pediatric epilepsy. Non-invasive investigation of cerebral metabolism.
Neonatal seizures, glucose metabolism in insulin dependent diabetes,
and phenylketonuria. Investigation of cerebral metabolism and function
by nuclear magnetic resonance spectroscopy. Neurometabolic disorders,
metabolism of epilepsy, developmental changes in cerebral metabolism,
interrelationship of metabolism, neuronal function and physiology,
metabolic regulation of ion channels and amino acid neurotransmitters.
Glial-neuronal metabolic interactions. |
 |
Petroff,
Ognen A.C., M.D.
|
Nuclear magnetic resonance spectroscopy and studies of cerebral metabolism.
Glutamate and GABA metabolism in epilepsy. In vivo brain pharmacology
of antiepileptic drugs. Apparent diffusion coefficient of brain water
mapping in epilepsy. Brain water relaxometry MRI in epilepsy. In vivo
cerebral metabolism measured by 13C labeled tracers. |
|
Rakic,
Pasko, M.D., Ph.D. |
Cellular
events and molecular mechanisms that govern development of the mammalian
CNS. Effects of various epigenetic factors on the development of structural,
molecular and functional cell phenotypes, and their segregation into
topographic maps and synaptic neurotransmitters/receptors architecture
in laminated structures (cerebellum, hippocampus, neocortex).
|
Richerson,
George B., M.D., Ph.D.
|
Effect
of PCO2 and pH on ion channel functions. Neural control of breathing,
and neurobiological substrates of disorders of breathing. Mechanisms
of action on anticonvulsants. Role of seratonin in brain function.
|
Shaywitz,
Bennett A., M.D.
|
Functional
organization of the brain for reading and language using functional
magnetic resonance imaging; reading and language related processes:
classification/definition of learning and attention disorders.
|
Spencer,
Susan S., M.D.
|
Localization of epileptic foci, application and interpretation of
intracranial EEG, seizure spread patterns, outcome after epilepsy
surgery, quality of life measurement and findings in epilepsy and
after various treatments. |
Strittmatter, Stephen.,
M.D., Ph.D.
|
Axonal regeneration and functional neurologic recovery after CNS injury,
axon growth inhibitors in adult CNS, signal transduction mechanisms
underlying semaphorin-directed neuronal development. |
|
Waxman,
Stephen G., M.D., Ph.D. |
Molecular
neurobiology of neurobiological diseases, with emphasis on neural
plasticity, functional recovery, and regeneration. Ion channel organization
within normal and injured neurons and glial cells. |
 |
Last Modified: Jan 2007


    
 

©
Copyright Department of Neurology, Yale School of Medicine.
All rights reserved.
|